InvestLog
REPL Replimune Group, Inc. logo

REPL Replimune Group, Inc.

Healthcare
$4.57+0.00%OpenMarket Cap: $376.9M

As of 2026-05-26

Insider Statistics (Q2 2026)

Acquisitions

19

Dispositions

8

Buy/Sell Ratio

2.38

Net Shares

+1,402,597

Shares Acquired

1,539,100

Shares Disposed

136,503

Total Bought ($)

$0.00

Total Sold ($)

$7.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Wed May 20Xynos Konstantinosofficer: Chief Medical OfficerSell14,023$5.08235,662
Wed May 20Schwendenman Andrewofficer: Chief Accounting OfficerSell7,894$5.08107,057
Wed May 20Sarchi Christopherofficer: Chief Commercial OfficerSell8,626$5.08192,962
Wed May 20Patel Sushildirector, officer: Chief Executive OfficerSell37,324$5.08747,492
Wed May 20Hill Emily Luisaofficer: Chief Financial OfficerSell7,812$5.08236,556
Wed May 20Astley-Sparke PhilipdirectorSell17,657$5.081,412,414
Tue Apr 07Xynos Konstantinosofficer: Chief Medical OfficerSell75,000$7.6175,000
Tue Apr 07Xynos Konstantinosofficer: Chief Medical OfficerSell50,000$0.00249,685
Tue Apr 07Schwendenman Andrewofficer: Chief Accounting OfficerSell36,667$0.00114,951
Tue Apr 07Sarchi Christopherofficer: Chief Commercial OfficerSell75,000$7.6175,000
Tue Apr 07Sarchi Christopherofficer: Chief Commercial OfficerSell50,000$0.00201,588
Tue Apr 07Oliger Christy J.directorSell44,500$7.6144,500
Tue Apr 07Balachandran MadhavandirectorSell44,500$7.6144,500
Tue Apr 07BAKER BROS. ADVISORS LPdirector, 10 percent owner: Sell44,500$7.6144,500
Tue Apr 07Astley-Sparke PhilipdirectorSell75,000$7.6175,000